We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Allergan’s Paragraph IV ANDA for Tyvaso Triggers Lawsuit
Allergan’s Paragraph IV ANDA for Tyvaso Triggers Lawsuit
United Therapeutics has filed suit in federal court in New Jersey, claiming Allergan’s Paragraph IV ANDA for a generic version of its hypertension drug Tyvaso violates three of the drug’s patents.